title: Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
abstract: The binding of [3H]forskolin to a homogeneous population of binding sites in rat striatum was enhanced by NaF, guanine nucleotides and MgCl2. These effects of NaF and guanylylimidodiphosphate (Gpp(NH)p) were synergistic with MgCl2, but NaF and Gpp(NH)p together elicited no greater enhancement of [3H]forskolin binding. These data suggest that [3H]forskolin may label a site which is modulated by the guanine nucleotide regulatory subunit which mediates the stimulation of adenylate cyclase (NS). The D1 dopamine receptor is known to stimulate adenylate cyclase via NS. In rat striatum, the Bmax of [3H]forskolin binding sites in the presence of MgCl2 and NaF was approximately two fold greater than the Bmax of [3H]SCH23390-labeled D1 dopamine receptors. Incubation of striatal homogenates with the protein modifying reagent EEDQ elicited a concentration-dependent decrease in the binding of both [3H]SCH23390 and [3H]forskolin, although EEDQ was approximately 14 fold more potent at inactivating the D1 dopamine receptor. Following in vivo administration of EEDQ there was no significant effect on [3H]forskolin binding sites using a dose of EEDQ that irreversibly inactivated greater than 90% of D1 dopamine receptors. These data suggest that EEDQ is a suitable tool for investigating changes in the stoichiometry of receptors and their second messenger systems.
authors.affiliation: Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267-0559.
authors.forename: A B
authors.initials: AB
authors.lastname: Norman
authors.forename: T J
authors.initials: TJ
authors.lastname: Wachendorf
authors.forename: P R
authors.initials: PR
authors.lastname: Sanberg
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000378:metabolism*; D001665:Binding Sites / Q000187:drug effects; D005576:Colforsin / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D015636:Magnesium Chloride; D008297:Male; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects; D015290:Second Messenger Systems / Q000187:drug effects; D012969:Sodium Fluoride / Q000494:pharmacology
chemical_list: D001552:Benzazepines; D011804:Quinolines; D011954:Receptors, Dopamine; D015636:Magnesium Chloride; D005576:Colforsin; D006165:Guanylyl Imidodiphosphate; C000470:EEDQ; D012969:Sodium Fluoride; D008274:Magnesium